Literature DB >> 12823547

Inactivation of phosphorylase is a major component of the mechanism by which insulin stimulates hepatic glycogen synthesis.

Susan Aiston1, Matthew P Coghlan, Loranne Agius.   

Abstract

Multiple signalling pathways are involved in the mechanism by which insulin stimulates hepatic glycogen synthesis. In this study we used selective inhibitors of glycogen synthase kinase-3 (GSK-3) and an allosteric inhibitor of phosphorylase (CP-91149) that causes dephosphorylation of phosphorylase a, to determine the relative contributions of inactivation of GSK-3 and dephosphorylation of phosphorylase a as alternative pathways in the stimulation of glycogen synthesis by insulin in hepatocytes. GSK-3 inhibitors (SB-216763 and Li+) caused a greater activation of glycogen synthase than insulin (90% vs. 40%) but a smaller stimulation of glycogen synthesis (30% vs. 150%). The contribution of GSK-3 inactivation to insulin stimulation of glycogen synthesis was estimated to be less than 20%. Dephosphorylation of phosphorylase a with CP-91149 caused activation of glycogen synthase and translocation of the protein from a soluble to a particulate fraction and mimicked the stimulation of glycogen synthesis by insulin. The stimulation of glycogen synthesis by phosphorylase inactivation cannot be explained by either inhibition of glycogen degradation or activation of glycogen synthase alone and suggests an additional role for translocation of synthase. Titrations with the phosphorylase inactivator showed that stimulation of glycogen synthesis by insulin can be largely accounted for by inactivation of phosphorylase over a wide range of activities of phosphorylase a. We conclude that a signalling pathway involving dephosphorylation of phosphorylase a leading to both activation and translocation of glycogen synthase is a critical component of the mechanism by which insulin stimulates hepatic glycogen synthesis. Selective inactivation of phosphorylase can mimic insulin stimulation of hepatic glycogen synthesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823547     DOI: 10.1046/j.1432-1033.2003.03648.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  The role of protein kinase B/Akt in insulin-induced inactivation of phosphorylase in rat hepatocytes.

Authors:  S Aiston; L J Hampson; C Arden; P B Iynedjian; L Agius
Journal:  Diabetologia       Date:  2005-12-10       Impact factor: 10.122

2.  Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.

Authors:  Tracy P Torres; Noriyasu Sasaki; E Patrick Donahue; Brooks Lacy; Richard L Printz; Alan D Cherrington; Judith L Treadway; Masakazu Shiota
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

3.  Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs.

Authors:  Nikos G Oikonomakos; Magda N Kosmopoulou; Evangelia D Chrysina; Demetres D Leonidas; Ioannis D Kostas; K Ulrich Wendt; Thomas Klabunde; Elisabeth Defossa
Journal:  Protein Sci       Date:  2005-07       Impact factor: 6.725

4.  Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site.

Authors:  Evangelia D Chrysina; Magda N Kosmopoulou; Constantinos Tiraidis; Rozina Kardakaris; Nicolas Bischler; Demetres D Leonidas; Zsuzsa Hadady; Laszlo Somsak; Tibor Docsa; Pal Gergely; Nikos G Oikonomakos
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

5.  "Fluorescent glycogen" formation with sensibility for in vivo and in vitro detection.

Authors:  M Carmen Louzao; Begoña Espiña; Mercedes R Vieytes; Felix V Vega; Juan A Rubiolo; Otto Baba; Tatsuo Terashima; Luis M Botana
Journal:  Glycoconj J       Date:  2007-11-01       Impact factor: 2.916

6.  Differential regulation of glycogenolysis by mutant protein phosphatase-1 glycogen-targeting subunits.

Authors:  Arpad M Danos; Senad Osmanovic; Matthew J Brady
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

7.  An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia.

Authors:  S M Poucher; S Freeman; S J G Loxham; G Convey; J B Bartlett; J De Schoolmeester; J Teague; M Walker; A V Turnbull; A D Charles; F Carey; S Berg
Journal:  Br J Pharmacol       Date:  2007-10-15       Impact factor: 8.739

8.  PP2A inhibition results in hepatic insulin resistance despite Akt2 activation.

Authors:  Thomas Galbo; Rachel J Perry; Erica Nishimura; Varman T Samuel; Bjørn Quistorff; Gerald I Shulman
Journal:  Aging (Albany NY)       Date:  2013-10       Impact factor: 5.682

Review 9.  Pancreatic regulation of glucose homeostasis.

Authors:  Pia V Röder; Bingbing Wu; Yixian Liu; Weiping Han
Journal:  Exp Mol Med       Date:  2016-03-11       Impact factor: 8.718

Review 10.  Insights into the Hexose Liver Metabolism-Glucose versus Fructose.

Authors:  Bettina Geidl-Flueck; Philipp A Gerber
Journal:  Nutrients       Date:  2017-09-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.